abagovomab 40
abciximab 38
abituzumab 24
abrilumab 24
actoxumab 21
adalimumab 22
aducanumab 16
afasevikumab 21
alacizumab_pegol 13
alemtuzumab 37
alirocumab 23
amatuximab 50
andecaliximab 28
anifrolumab 24
anrukinzumab 24
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 26
ascrinvacumab 8
atezolizumab 16
atinumab 17
avelumab 15
basiliximab 38
bavituximab 44
begelomab 33
benralizumab 34
bevacizumab_beta 26
bezlotoxumab 21
bimagrumab 23
bleselumab 22
blinatumomab 38
blosozumab 32
bococizumab 21
brazikumab 19
brentuximab_vedotin 39
briakinumab 21
brodalumab 21
brolucizumab 30
brontictuzumab 29
burosumab 23
cabiralizumab 31
camrelizumab 16
canakinumab 28
cantuzumab_ravtansin 52
carlumab 17
carotuximab 30
cergutuzumab_amunaleukin2 34
cergutuzumab_amunaleukin 34
certolizumab_pegol 27
cetiximab 52
citatuzumab_bogatox 30
cixutumumab 32
clivatuzumab_tetraxetan 33
codrituzumab 34
conatumumab 14
concizumab 33
crenezumab 24
crizanlizumab 30
crotedumab 22
dacetuzumab 26
daclizumab 23
dalotuzumab 44
dapirolizumab_pegol 29
daratumumab 14
dectrekumab 11
demcizumab 32
denosumab 10
depatuxizumab 33
depatuxizumab_mafodotin 33
dezamizumab 25
dinutuximab 43
diridavumab 31
domagrozumab 18
drozitumab 26
duligotuzumab 21
durvalumab 14
dusigitumab 26
efalizumab 37
efungumab 31
eldelumab 19
elezanumab 25
elgemtumab 14
elotuzumab 21
emactuzumab 28
emapalumab 31
emibetuzumab 27
enavatuzumab 27
enfortumab_vedotin 15
enoblituzumab 21
enokizumab 28
enoticumab 21
ensituximab 42
eptinezumab 20
erenumab 25
etaracizumab 18
etrolizumab 25
evinacumab 24
evolocumab 23
farletuzumab 16
fasinumab 30
fezakinumab 28
fibatuzumab 17
ficlatuzumab 26
firivumab 38
flanvotumab 24
fletikumab 30
foralumab 16
foravirumab 17
fremanezumab 32
fresolimumab 19
fulranumab 22
futuximab 36
galcanezumab 23
ganitumab 31
gantenerumab 14
gemetuzumab 36
gemtuzumab2 28
gemtuzumab 31
gevokizumab 30
girentuximab 35
glembatumumab 22
glembatumumab_vedotin 22
guselkumab 25
ibalizumab 31
ibritumomab 44
icrucumab 14
idarucizumab 41
ifabotuzumab 17
imalumab 19
imgatuzumab 25
inclacumab 21
indatuximab_ravtansin 41
indusatumab 23
inebilizumab 31
intetumumab 18
iodine_girentuximab 31
ipilimumab 8
iratumumab 18
isatuximab 42
itolizumab 28
ixekizumab 36
labetuzumab_govitecan 27
lambrolizumab 32
lampalizumab 31
lanadelumab 19
landogrozumab 19
laprituximab 33
lebrikizumab 42
lendalizumab 28
lenzilumab 21
lifastuzumab_vedotin 26
ligelizumab 25
lilotomab 45
lirilumab 26
lodelcizumab 21
lokivetmab 27
lorvotuzumab_mertansin 29
lucatumumab 31
lumretuzumab 25
lupartumab 18
lutikizumab 23
margetuximab 43
milatuzumab 45
mirvetuximab 43
mirvetuximab_soravtansin 43
modotuximab 47
mogamulizumab 36
monalizumab 27
motavizumab 43
moxetumomab_pasudotox 35
namilumab 30
naratuximab 36
naratuximab_emtansin 36
narnatumab 21
navicixizumab2 30
navicixizumab 33
navivumab 41
necitumumab 12
nemolizumab 32
nesvacumab 18
nivolumab 14
obiltoxaximab 25
obinutuzumab 36
ocaratuzumab 29
ofatumumab 20
olaratumab 22
olokizumab 28
omalizumab 22
onartuzumab 25
ontuxizumab 37
opicinumab 15
orticumab 17
otelixizumab 42
oxelumab 13
ozanezumab 37
pamrevlumab 13
panobacumab 31
parsatuzumab 30
pasotuxizumab 23
pateclizumab 21
patritumab 29
pembrolizumab 32
perakizumab 25
pidilizumab 27
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 28
polatuzumab_vedotin 24
ponezumab 40
prezalumab 17
pritoxaximab 45
quilizumab 23
racotumomab 36
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 33
ranibizumab 26
refanezumab 27
remtolumab 21
rilotumumab 25
rinucumab 21
risankizumab 38
rituximab 28
rivabazumab 26
robatumumab 20
roledumab 37
romosozumab 30
rontalizumab 26
rosmantuzumab 31
rozanolixizumab 26
sacituzumab 35
sacituzumab_govitecan 35
samalizumab 29
sapelizumab 25
sarilumab 18
secukinumab 19
seribantumab 18
setoxaximab 53
sifalimumab 18
siltuximab 29
simtuzumab 31
sirukumab 13
solanezumab 28
solitomab 34
stamulumab 24
suptavumab 28
suvizumab 27
tabalumab 19
tadocizumab 22
tamtuvetmab 37
tanezumab 27
tarextumab 13
tavolixizumab 23
telisotuzumab 33
teplizumab 27
tesidolumab 26
tezepelumab 27
tigatuzumab 18
tildrakizumab 25
timolumab 18
tisotumab 16
tosatoxumab 43
tositumomab 41
tralokinumab 35
trastuzumab 24
tregalizumab 25
trevogrumab 15
ublituximab 37
urelumab 27
ustekinumab 30
utomilumab 29
vadastuximab 33
vadastuximab_talirin 33
vandortuzumab_vedotin 22
vantictumab 25
vanucizumab2 26
vanucizumab 31
varlilumab 18
vatelizumab 28
vedolizumab 33
veltuzumab 22
vesencumab 12
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 43
xentuzumab 21
zatuximab 47
